S12 - Understanding the Evidence about Obesity Management in People with T1D

Saturday, August 9, 2025

1:15 PM - 2:00 PM MST

CE/CME Hours: .75 CE

Pharmacology Hours: .25 CE

The rates of obesity in people with T1D are now similar to the general US population. Therapies for obesity have been studied in people with T2D, but people with T1D were excluded from large, randomized trials. Treatment of obesity in T1D is complicated by the limits of clinical evidence and the complexity of insulin management. This session explores factors that contribute to weight gain in T1D, and the challenges of insulin therapy during weight loss. Evidence for weight management therapies in T1D will be reviewed, and the role of the DCES to support weight loss will be highlighted.

Disclosure(s):

Caitlin Nass, MSN, NP: Corcept: Consultant / Advisory Board (Ongoing); Sanofi: Consultant / Advisory Board (Ongoing), Scientific education program speaker (Ongoing)

Primary Presenter(s)

Caitlin Nass, MSN, NP (she/her/hers)

Clinical Director, Diabetes Transformation
UM Baltimore Washington Medical Center
Arnold, Maryland

Disclosure(s): Corcept: Consultant / Advisory Board (Ongoing); Sanofi: Consultant / Advisory Board (Ongoing), Scientific education program speaker (Ongoing)

Session Host(s)

Christie Beatson, RD, CDCES (she/her/hers)

Sr. Instructor
Barbara Davis Center, University of Colorado
Aurora, Colorado

Disclosure information not submitted.